James L. Freddo

Chief Medical Officer at Oncternal Therapeutics, Inc.

James L. Freddo

James L. Freddo

Chief Medical Officer at Oncternal Therapeutics, Inc.

Overview
Career Highlights

Pfizer, Inc.

RelSci Relationships

3191

Number of Boards

6

Birthday

1955

Age

63

Relationships
RelSci Relationships are individuals James L. Freddo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Bonti, Inc.

Relationship likelihood: Strong

Former National Chairman, Medicinal Chemistry in American Chemical Society Division at Gordon Research Conference on Nonlinear Optics & Lasers

Relationship likelihood: Strong

Former President, Chief Executive Officer, Chief Financial Officer, Treasurer, Director & CAO at Infinity Oil & Gas Co.

Relationship likelihood: Strong

Director & Chief Scientific Officer at Selexagen Therapeutics, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Ignyta Operating, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Reneo Capital Management LP

Relationship likelihood: Strong

Venture Partner, Biotechnology at SV Life Sciences Advisers LLP

Relationship likelihood: Strong

Co-Founder at Exelixis, Inc.

Relationship likelihood: Strong

Co-Founder at Effector Therapeutics, Inc.

Relationship likelihood: Strong

Founder at SENTÉ, Inc. (California)

Relationship likelihood: Strong

Paths to James L. Freddo
Potential Connections via
Relationship Science
You
James L. Freddo
Chief Medical Officer at Oncternal Therapeutics, Inc.
Education
MD Unknown

The University of North Carolina at Chapel Hill also known as UNC, UNC-Chapel Hill, Chapel Hill, North Carolina, or simply Carolina is a coeducational public research university located in Chapel Hill, North Carolina, United States. North Carolina has been consistently ranked among the highest ranked universities in the United States and is one of the original eight Public Ivy schools that provide an Ivy League experience for a public schooling price. After being chartered in 1789, the university first began enrolling students in 1795, which allows it to be one of three schools to claim the title of the oldest public university in the United States.

Stony Brook University is one of America’s most dynamic public universities, a center of academic excellence and an internationally recognized research institution that is changing the world. After less than 60 years of existence, it’s ranked among the top 100 universities in the nation.

Career History
Chief Medical Officer
Tenure Unconfirmed

Oncternal Therapeutics, Inc. operates as a clinical-stage oncology company. The firm develops first-in-class and novel therapies for both rare and common cancers. The company is headquartered in San Diego, CA.

Chief Medical Officer
Prior - 2018

Ignyta, Inc. is a precision oncology biotechnology company that engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. It plans focus on two product candidates: entrectinib, a tyrosine kinase inhibitor directed to the Trk family tyrosine kinase receptors ROS1 and ALK proteins, which is in two Phase I/II clinical studies in molecularly defined patient populations for the treatment of solid tumors; and RXDX-103, a development program targeting the cell division cycle 7-related, or CDC7, protein kinase. The company was founded by Jonathan E. Lim on October 31, 2013 and is headquartered in San Diego, CA.

Chief Medical Officer
Prior - 2014

Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA.

Boards & Committees
Independent Director
2014 - 2018

Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA.

Director
2008 - 2011

Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is an American company located in Madison Heights, MI, that manufactures external ambulatory infusion pumps. HAPC, Inc. acquired InfuSystem, Inc. from I-Flow Corp. on 26 Oct 07 for $112 million.

Director
2008 - 2011

InfuSystem Holdings, Inc. engages in the provision of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites. The firm also provides its products and services to hospitals, oncology practices and facilities and other alternate site health care providers. The company was founded in August 2005 and headquartered in Madison Heights, MI.

Transactions
Details Hidden

Oncternal Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Oncternal Therapeutics, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James L. Freddo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James L. Freddo's profile does not indicate a business or promotional relationship of any kind between RelSci and James L. Freddo.